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Percutaneous Nephroscopic Surgery
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With the development of techniques for percutaneous access and equipment to dis-
integrate calculi, percutaneous nephroscopic surgery is currently used by many urolo-
gists and is the procedure of choice for the removal of large renal calculi and the manage-
ment of diverticula, intrarenal strictures, and urothelial cancer. Although it is more 
invasive than shock wave lithotripsy and retrograde ureteroscopic surgery, percuta-
neous nephroscopic surgery has been successfully performed with high efficiency and 
low morbidity in difficult renal anatomies and patient conditions. These advantages 
of minimal invasiveness were rapidly perceived and applied to the management of ure-
teropelvic junction obstruction, calyceal diverticulum, infundibular stenosis, and ur-
othelial cancer. The basic principle of endopyelotomy is a full-thickness incision of the 
narrow segment followed by prolonged stenting and drainage to allow regeneration of 
an adequate caliber ureter. The preferred technique for a calyceal diverticulum con-
tinues to be debated. Excellent long-term success has been reported with percutaneous, 
ureteroscopic, and laparoscopic techniques. Each approach is based on the location and 
size of the diverticulum. So far, percutaneous ablation of the calyceal diverticulum is 
the most established minimally invasive technique. Infundibular stenosis is an ac-
quired condition usually associated with inflammation or stones. Reported series of per-
cutaneously treated infundibular stenosis are few. In contrast with a calyceal divertic-
ulum, infundibular stenosis is a more difficult entity to treat with only a 50-76% success 
rate by percutaneous techniques. Currently, percutaneous nephroscopic resection of 
transitional cell carcinoma in the renal calyx can be applied in indicated cases.
Key Words: Diverticulum; Hydrocalycosis; Percutaneous nephrostomy; Transitional 
cell carcinoma; Urinary calculi
Article History:
received 25 April, 2010
accepted 4 May, 2010
Corresponding Author:
Tae-Kon Hwang
Department of Urology, Seoul St. 
Mary’s Hospital, College of Medicine, 
The Catholic University of Korea, 505, 
Banpo-dong, Seocho-gu, Seoul 
Korea
TEL: +82-2-2258-6225
FAX: +82-2-596-1386
E-mail: tkhwang@catholic.ac.kr
Most of this article was previously 
published in Recent Advances in 
Endourology [1]. It is presented here 
under the permission of JSEE.
HISTORY
Percutaneous renal puncture was first described in 1955 
by Goodwin and Casey, who placed a trocar directly into the 
collecting system [2]. Later, the Seldinger method of neph-
rostomy placement was adopted, in which a fine guide wire 
is placed into the collecting system through the core of the 
needle that was used to perform the initial renal puncture. 
A coaxial catheter can then be placed over this initial guide 
wire and the renal pelvis drained even if it was not dilated. 
The addition of a preformed pigtail to these nephrostomy 
catheters ensured that they could not be easily displaced 
from the pelvis. In 1976 Fernstrom and Johansson de-
scribed a method of dilating such an antegrade neph-
rostomy by use of graded plastic dilators introduced co-
axially down the track [3]. After a number of days, the tract 
was used for intrarenal manipulation utilizing Dormia 
baskets and other grasping tools. Currently, the percuta-
neous tract can be dilated by acute dilation with a balloon 
catheter. Percutaneous nephrostomy (PCN) is, and will 
continue to be, the cornerstone of every percutaneous pro-
cedure of the upper urinary tract. 
ANATOMY FOR PERCUTANEOUS SURGERY
The topographical position of the kidney depends on its em-
bryological development. Classically, the pelvis lies oppo-
site the lower border of the first lumbar vertebra on the 
right and slightly higher on the left. 
　Among numerous factors, enveloping fascia, vascular 
connections, and intra-abdominal pressure are probably 
the most important factors holding the kidney in position. Korean J Urol 2010;51:298-307
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Within the renal fascia, the surrounding fat allows a consid-
erable amount of renal movement despite its apparent den-
sity, although the kidney is tethered by the short vessels 
rigidly anchored to their midline connections. Abdominal 
tone provided by the anterior abdominal wall may be the 
most important factor for renal stability. The position of the 
liver limits the cranial movement of the kidney on the right 
side. The proximity of the pancreas to the anterior aspect 
of the left kidney is said to be especially important in limit-
ing the movement of the kidney. The suprarenal attach-
ments and ligaments to the liver and duodenum probably 
do not play an important role in maintaining renal position 
[2].
　Movement of the diaphragm in respiration causes the 
kidney to move downward in inspiration and upward in 
expiration. The amplitude of movement is very variable, 
but it is usually within 3-5 cm. Such movement is more pro-
nounced in women than in men and in the right than in the 
left kidney. When the patient is in the prone position with 
bolsters under the chest and upper abdomen, the kidneys 
are further displaced in a cephalad direction.
RENAL VASCULAR ANATOMY
The main renal artery divides into two main branches, the 
anterior and the posterior. The anterior division further 
subdivides into the four anterior segmental arteries, which 
supply the anterior and polar areas of the kidney. The pos-
terior segmental artery supplies the rest of the posterior 
area of the kidney. In more than 50% of kidneys, the posteri-
or segmental artery is located in the middle or upper half 
of the posterior renal surface, and it may be damaged with 
an excessively medial needle puncture of an upper calyx. 
The segmental arteries divide into the interlobar arteries 
after crossing the renal sinus and become the arcuate ar-
teries at the corticomedullary junction. The interlobular 
arteries branch off the arcuate arteries at right angles. The 
Brödel line delineates an avascular plane between the an-
terior and the posterior blood supplies. By taking a postero-
lateral transparenchymal path, the needle traverses the 
area of the Brödel line, and damage to major blood vessels 
can be avoided. A direct posterior puncture that is too me-
dial risks injury to the posterior segmental artery, which 
is the artery most commonly injured in endourologic 
procedures. A needle directed end-on to a posterior calyx 
passes transparenchymally, and the chance of significant 
bleeding is minimized.
PERCUTANEOUS NEPHROLITHOTOMY (PNL)
Although Rupel and Brown first removed a renal calculus 
through an operatively established nephrostomy tract in 
1941 [4], the first PNL via a nephrostomy tract created for 
the sole purpose of stone removal was performed in 1976 
by Fernstrom and Johansson [2]. The introduction of this 
technique was further refined over the years. As operative 
technique and endoscopic equipment improved, PNL was 
performed with increasing efficacy and decreasing compli-
cations [5]. PNL has replaced open techniques in removing 
complex urinary calculi in most institutions. In Korea, the 
first PNL was performed in 1984 by Koh et al [6]. This oper-
ation has now spread to several other institutes in Korea 
[7-9].
　The practice of PNL has changed over time and is con-
tinuing to evolve. Differing aspects of the procedure, such 
as the ideal dilating method, the type of nephrostomy tube 
used, and the technique of treating calyceal diverticula, 
have been debated. Even the need for a nephrostomy tube 
has been questioned. 
1. Technique
I want to first introduce the usual method of performing 
percutaneous surgery, and each different method will be 
discussed later. An open-ended 5-6 Fr ipsilateral ureteral 
catheter or occlusion balloon catheter is passed, allowing 
the injection of contrast material to opacify and distend the 
collecting system. Once the ureteral catheter is inserted, 
the patient is placed in a prone position on a C-arm compat-
ible table. The patient can also be placed in a lateral posi-
tion and punctured under the guidance of ultrasono-
graphy. Bolsters are placed next to the patient and a sterile 
drape is applied to the C-arm, enabling its manipulation 
by the surgeon. 
　The radiation source is positioned under the patient to 
minimize scattered radiation exposure to the surgeon. The 
emission tube is shielded by an additional layer of material, 
which also reduces the scattered radiation to the operator. 
　It is very important to select the percutaneous tract. The 
preferred approach is by way of a posterior calyx because 
major vascular structures surrounding the renal pelvis can 
be avoided and the transparenchymal route stabilizes the 
catheter in an appropriate position. Approach through a 
short tract perpendicular to the convexity of the kidney 
causes minimal anatomical or functional damage if the 
tract is dilated by using a graded coaxial dilator. A puncture 
either too medial or too lateral will enter the renal pelvis 
directly. Direct puncture of the renal pelvis should be 
avoided because it carries a significant risk of injury to the 
posterior branch of the renal artery. Furthermore, the tract 
created from such a puncture provides no stability for the 
nephrostomy tube because it lacks parenchymal support. 
A computerized tomogram taken in a prone position could 
be helpful in a patient with anatomical abnormalities such 
as a horseshoe kidney. After opacification of the collecting 
system by injection of a contrast material through the ure-
teral catheter, a puncture is performed in mid-inspiration 
by use of the sheathed needle. The puncture tract should 
be straight to the aimed calyx to prevent a false tract during 
dilation. The position of the needle tip should be checked 
intermittently by rotating the C-arm. When the needle ap-
pears to be in a calyx, the stylet is removed while the sheath 
is a little bit advanced in position to the calyx, and the cor-
rect needle position is verified by aspiration of urine. At 
times, aspiration of urine might be delayed due to increased Korean J Urol 2010;51:298-307
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FIG. 1. Percutaneous nephrolithotomy 
(PNL) with 8 ports in a solitary kidney. 
(A) Staghorn calculi with narrow in-
fundibulum. (B) After first PNL with 3 
ports (arrows). (C) After second PNL 
with 5 more ports.
mucosity with injected contrast medium or not enough 
space between the stone and the calyx. Next, the guide wire 
is inserted and advanced with the sheath held immobile by 
the other hand. The guide wire is advanced until resistance 
is encountered, and its position is checked by the C-arm at 
this time. The puncture could be performed under the guid-
ance of ultrasonography. It is easy to make a nephrostomy 
tract, but dilation of the tract should be performed under 
fluoroscopy.
　If one has punctured into a calyx whose neck is filled by 
a stone, it may be difficult to pass the guide wire into the 
pelvis. In most of these situations, however, there is a nar-
row space between the stone and the calyx and one can try 
to manipulate the guide wire (sometimes a J-tipped guide 
wire) beyond the stone by using and in-and-out movement 
of the puncture needle or a preformed catheter such as a 
‘cobra’ catheter. It is not recommended to dilate over the 
guide wire when the stiff portion of the guide wire has not 
passed to the calyx or pelvis, because of the great possibility 
of ‘flipping’ the wire out of the system during dilation and 
thereby losing the tract. 
　After the guide wire is well positioned, the needle is re-
moved and a 1 cm incision is made at the wire site. The tract 
is dilated over the guide wire up to 26-30 Fr. Efficient dila-
tion is dependent on maintaining the same track through-
out the procedure, so that each dilator is following the same 
path into the kidney. The wire must be stiff enough to sup-
port the dilatation. Ideally, it reaches down the ureter into 
the bladder to avoid dislodgment during the use of the fas-
cial dilators. When placement of the guide wire down the 
ureter is not feasible, positioning it in a calyx that is distant 
from the initial nephrostomy tract prevents its dislodg-
ment during dilatation. Some urologists advocate the use 
of a second, safety guide wire in addition to the initial work-
ing guide wire. This safety wire is inserted adjacent to the 
working wire, its goal being to maintain access to the neph-
rostomy tract if the working wire is kinked or displaced. 
This safety wire is kept until the whole surgical procedure 
is finished. 
　A variety of techniques can be utilized to perform the 
tract dilatation. The most commonly used dilation techni-
ques are the Amplatz dilator set or the 10 cm, 24-30 Fr dilat-
ing balloon catheter and sheath set. Balloon dilation cathe-
ters of the 9 Fr size can dilate a nephrostomy tract to a diam-
eter of 24-30 Fr under pressure up to 16-20 atm in a one-step 
procedure. This may prove difficult or impossible if peri-
renal scar tissue from a previous surgery prevents com-
plete expansion of the balloon over its entire length. 
Sequential plastic dilators allow stepwise dilation of the 
tract under fluoroscopic control; however, on withdrawal 
for insertion of the next larger dilator, compression of the 
tract is lost intermittently and bleeding occurs into the col-
lecting system, sometimes hindering subsequent 
endoscopy. Coaxial metal dilators (each dilator slides over 
the next smaller one) allow stepwise tract dilation even in 
the presence of severe scarring with continuous neph-
rostomy tract compression for improved hemostasis. With 
any dilation technique, the last step is insertion of a work-
ing sheath, which may be either the 24-26 Fr metal working 
sheath of the nephroscope or a larger plastic sheath. A 
28-30 Fr plastic working sheath is preferable to a metal 
nephroscope sheath in all cases in which extensive, pro-
longed instrumentation is anticipated (e.g., staghorn 
stones). Larger plastic sheaths not only provide better irri-
gation with lower intrapelvic pressures than do con-
tinuous-flow nephroscope sheaths but also allow easier ex-
traction of large stone fragments. The stone can be frag-
mented with intracorporeal lithotriptors (e.g., holmium: 
YAG laser, the electrohydraulic lithotripter, ultrasonic 
lithotriptor, the pneumatic lithotriptor, and a combination 
ultrasonic-pneumatic device) and removed with various 
kinds of forceps and baskets.
　How many tracts are enough to remove all of the stone? 
The fewer the number of punctures, the better the overall 
renal functional outcome. But to achieve a better stone-free 
rate, one can make multiple accesses. I had a patient with 
a staghorn calculi in a solitary kidney who was treated with 
8 percutaneous tracts to remove all of the muddy caliceal 
stones (Fig. 1). But the factors associated with significant 
blood loss are diabetes, multiple tracts, prolonged oper-Korean J Urol 2010;51:298-307
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FIG. 2. Arteriovenous fistula from per-
cutaneous nephrolithotomy (PNL). (A) 
Angiographic appearance. (B) After 
successful selective arterial emboli-
zation.
ative times, and the occurrence of intraoperative complica-
tions [10].
　Percutaneous drainage of the pelvicaliceal system is rou-
tine after most endourologic approaches to the upper uri-
nary tract. Some authors argue that there is no need for a 
drainage tube after certain percutaneous procedures [11]. 
Nevertheless, there seems to be concurrence in the liter-
ature regarding the need for postoperative drainage with 
a nephrostomy tube after percutaneous procedures. The 
desired function of the nephrostomy tube greatly influen-
ces the choice of which drainage method to adopt. The main 
function of a nephrostomy tube is the drainage of urine and 
possibly the tamponade of bleeding originating from the 
structures acutely expanded during dilatation. Kader and 
colleagues [12] reported that a small drainage catheter was 
associated with a shorter median length of hospital stay 
and a lesser analgesic requirement but no difference in the 
mean hemoglobin decrease compared with a large drain-
age catheter.
　The success rates differ with the size, location, and com-
position of the stones; the collecting system anatomy; the 
endoscopic energy source; and the presence or absence of 
hydronephrosis [13]. 
2. Complications
Bleeding is the most significant complication of PNL, with 
transfusion rates varying from less than 1% to 10%. Blee-
ding from an arteriovenous fistula or pseudoaneurysm re-
quiring emergency embolization is seen in less than 0.5% 
of patients (Fig. 2) [14]. Most bleeding is venous in nature, 
and placement of a nephrostomy tube is usually adequate 
to control the bleeding. Clamping the nephrostomy tube for 
10 minutes is helpful in tamponading any persistent bleed-
ing [15]. Recently, there have been some reports of the use 
of fibrin glue to seal the nephrostomy tract following PCNL 
(tubeless) [16,17].
　PNL can lead to some absorption of irrigation fluid; 
therefore, the use of physiologic irrigating solutions is 
essential. The amount of absorbed fluid depends mostly on 
the irrigant pressure and the length of the procedure. 
Intraoperative administration of diuretics (e.g., mannitol 
12.5 g) is advisable and also has proved effective in prevent-
ing intrarenal reflux [18]. 
　When a supracostal puncture is performed, extra-
vasation of the irrigant may occur into the pleural cavity. 
The use of a working sheath tends to minimize extra-
vasation into the pleura because intrarenal pressure is low. 
The chest should be examined at the end of PNL procedures 
in which a supracostal puncture is used. When supracostal 
puncture is performed, the risk of a pneumothorax or pleu-
ral effusion requiring drainage is 4% to 12% [18,19]. 
Punctures above the 11th rib result in a tremendously 
higher intrathoracic complication rate (34.6%) compared 
with the supra 12th rib access (1.4%) [20]. These facts cor-
roborate the strategy of avoiding this high approach as 
much as possible. If the clinical findings suggest either of 
these complications, placement of a chest tube is mandatory. 
Immediate aspiration is performed, and the tube is re-
moved within 24 hours. If the hemothorax is extensive, a 
large chest tube is advisable. Pardalidis and Smith sug-
gested that in the case of nephrostomy access between the 
11th and 12th rib, approximately 10% of patients present 
with fluid accumulation within the pleural space [21]. 
Colonic injury is an unusual complication often diagnosed 
on a postoperative nephrostogram (Fig. 3). Colonic injury 
tends to occur in severe lean or retrorenal colon patients, 
so one should be careful not to injure the colon during punc-
ture and tract dilation in these patients. Typically, the in-
jury is retroperitoneal; thus, signs and symptoms of peri-
tonitis are infrequent. If the perforation is extraperitoneal, 
management may be expectant, with placement of a ure-
teral catheter or double-J stent to decompress the collect-
ing system and withdrawal of the nephrostomy tube from 
an intrarenal position to an intracolonic position to serve Korean J Urol 2010;51:298-307
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FIG. 3. Ascending colon injury of percutaneous nephrolithotomy 
(PNL) performed in a patient with a retrorenal colon. Extra-
vasated contrast medium is seen in the transverse and descen-
ding colon.
as a colostomy tube. The colostomy tube is left in place for 
a minimum of 7 days and is removed after a nephrostogram 
or a retrograde pyelogram showing no communication be-
tween the colon and the kidney [22,23]. Exploration is rec-
ommended if the colon injury is found late.
3. Effects on renal function
The effect of PNL on short-term differential renal function 
was examined with nuclear renography by Chatham et al 
[24]. 99m-Tc-mercaptoacetyl triglycine (MAG3) nuclear 
scans were performed preoperatively and postoperatively 
in 19 PNL patients. Nuclear renography at a median of 22 
days revealed stable differential function in the treated 
kidney. Renal function was previously assessed in ana-
trophic nephrolithotomy patients with MAG3 and a de-
crease from 42.0% preoperatively to 37.6% postoperatively 
was noted [25]. Liou and Streem assessed long-term renal 
function in patients with solitary kidneys after shockwave 
lithotripsy (SWL), PNL, or combined PNL/SWL therapy 
[26]. With the use of serum creatinine and calculated GFR, 
follow-up renal function revealed no statistically sig-
nificant change in any of the chosen therapeutic 
modalities. Although no significant differences in post-
operative renal function were found among the different 
therapy options, the PNL and combined therapy group had 
an average post-procedural increase in Cr by 0.5 mg/dl, as 
compared with a 0.1-mg/dl decrease in the SWL only group. 
　Although PNL was not introduced until the 1980s, the 
role of PNL is firmly entrenched. Kerbl et al noted that the 
number of percutaneous stone procedures had steadily in-
creased from 2068 cases to 2678 over the time period from 
1988 to 2000 [27]. Not surprisingly, the number of percuta-
neous procedures performed for stone burden greater than 
2 cm rose by 123%. These data confirm the recom-
mendation of the NIH Consensus Conference for primary 
percutaneous therapy for larger stone burdens. PNL con-
tinues to play an important role in treating lower pole 
calculi. Although many lower pole stones are treated ini-
tially with SWL or even ureteroscopy, the Lower Pole Study 
Group revealed a clear advantage of PNL in stones over 1.0 
cm [28]. The role of PNL as the primary therapy for lower 
pole calculi may accordingly increase. Although PNL is 
safe and effective, future studies may further refine the 
technique of PNL, help to minimize adverse effects, and 
thereby help to deliver better patient care.
PERCUTANEOUS ENDOPYELOTOMY
Endourologic management of ureteropelvic junction (UPJ) 
obstruction was introduced by Whitfield and Wickham in 
1983 as a ‘percutaneous pyelolysis’ and was popularized 
shortly thereafter by Smith, who coined the term 
‘endopyelotomy’ [29]. Despite various nuances in the name 
of the procedure and in the technique performed, the basic 
concept is constant and involves a full-thickness incision 
through the obstructing proximal ureter from the ureteral 
lumen out to the peripelvic and periureteral fat. The in-
cision is stented and left to heal based on the early work 
of Davis, who used an ‘intubated ureterotomy’ in the course 
of an open operative procedure for UPJ obstruction [30]. 
Smith introduced endopyelotomy with a live surgery work-
shop to Korean doctors in 1987. After that, endopyelotomy 
started to be reported in papers from Korea [31,32].
　Contraindications to a percutaneous endopyelotomy are 
similar to the contraindications to any endourologic ap-
proach and include a long segment (>2 cm) of obstruction, 
active infection, or untreated coagulopathy. The impact of 
crossing vessels is controversial [33-36]. 
　Compared with the retrograde techniques of endopyelot-
omy (incision with a cold knife, Acucise catheter, 
Greenwald electrode, or laser), the antegrade technique of-
fers the advantage of an incision under direct vision. The 
incision must be extended into the perirenal fat and into 
the healthy ureter. Although several clinicians suggest 
that the incision should always be made laterally, in fact, 
the ureter may be inserted into the renal pelvis on the ante-
rior or posterior wall. In such cases, the incision should in-
stead marsupialize the proximal ureter into the renal pel-
vis such that an anterior or posterior incision may be re-
quired [30]. Percutaneous endopyeloplasty, horizontal 
percutaneous suturing of a conventional longitudinal en-
dopyelotomy incision, was recently developed with good 
clinical results. The technical simplicity and shorter oper-
ative time are advantages compared with laparoscopic pye-
loplasty [37,38]. 
　Once the incision is complete, stenting is accomplished. 
A 14/7 Fr endopyelotomy stent can be used and is passed 
in an antegrade fashion with the large diameter end of the 
stent positioned across the UPJ. There was a trend for bet-
ter results with the use of a 14/7 Fr stent in patients with 
secondary stricture, although the difference in success Korean J Urol 2010;51:298-307
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TABLE 1. Contemporary results and follow-up of percutaneous endopyelotomy for primary and secondary UPJ obstruction
Authors Patients (n) Method of incision Year published Success rate (%) Mean F/U (months)
Knudsen et al [41] 80 (61/19) Cold knife 2004 67 (65/74) 55
Shalhav et al [42] 63 (40/23) Hot knife 1998 85 (89/77) 15
Danuser et al [33] 80 (80/0) Cold knife 1998 81 (81/NA) 26
Gupta et al [34] 401 (235/166) Cold Knife 1997 85 (82/89) 51
Data presented as overall value with data for primary/secondary UPJ obstruction in parentheses, UPJ: ureteropelvic junction, NA: 
not available, F/U: follow-up
rates between the 6 Fr and the 14/7 Fr stent was not sig-
nificant statistically [39]. 
　The immediate and long-term results of percutaneous 
endopyelotomy are well established. Clearly, percuta-
neous endopyelotomy compares favorably with open oper-
ative pyeloplasty in terms of postoperative pain, the length 
of hospital stay, and the return to prehospitalization activ-
ities [30,40]. Currently, success rates approaching 85% to 
90% are reported at experienced centers (Table 1). Little 
difference in outcome is noted between primary and secon-
dary UPJ obstruction and no difference in methods of 
incision.
　Laparoscopic pyeloplasty has recently been reported, 
with success rates in excess of 95% [43]. Moreover, laparo-
scopy and robot-assisted surgery can be applied in patients 
with severe hydronephrosis requiring pelvic reduction and 
in patients with crossing vessels that may require ureter-
al-vascular transposition. However, the steep learning 
curve in laparoscopic surgery or the economical condition 
may limit laparoscopic or robot-assisted pyeloplasty to se-
lect centers proficient in reconstructive laparoscopy or ro-
botic surgery. 
CALYCEAL DIVERTICULUM
A calyceal diverticulum is a smooth-walled, nonsecretory 
cavity in the renal parenchyma that is lined with transi-
tional cell epithelium. It receives urine by passive retro-
grade filling from the adjacent collecting system, usually 
through a narrow forniceal channel or infundibulum. 
Calyceal diverticula are believed to be congenital in origin, 
likely from failed degeneration of small ureteral buds. They 
are typically less than 1 cm in diameter with no predilection 
for sex or kidney side. Uncomplicated, asymptomatic caly-
ceal diverticula may be managed conservatively without 
routine follow-up imaging. However, because of their cyst-
ic, urine-containing nature, they are frequently associated 
with stone formation and infection and become sympto-
matic in up to one third of patients [44]. 
　Treatment of a calyceal diverticulum containing a stone 
has evolved from open surgical excision to SWL, to percuta-
neous and ureteroscopic ablative techniques. The pre-
ferred technique continues to be debated. Percutaneous 
management of the calyceal diverticulum is challenging 
because the cavity is often small, making localization for 
direct access difficult. The first Korean paper was reported 
in 1994 and the percutaneous process was mentioned [45]. 
Cystoscopy and ureteral balloon catheter placement is per-
formed in the renal pelvis. A balloon catheter is helpful to 
opacify the diverticulum with injection of contrast through 
the ureteral catheter to guide the percutaneous access, es-
pecially when the neck of the diverticulum is narrow. 
Direct puncture of the diverticulum is then made under flu-
oroscopic guidance, and a guide wire is coiled within it. 
Ideally, a polytetrafluoroethylene-coated or hydrophilic 
safety wire is placed through the diverticular neck into the 
renal pelvis, but it is usually coiled in the diverticular cav-
ity because the neck cannot be cannulated. Canales and 
Monga advocate dilation of the tract into the diverticulum, 
although not through the diverticular neck because the 
goal of the procedure is to ablate the cavity and the con-
nection to the collecting system [44]. Dilation of the diver-
ticular infundibulum could be viewed as counter-
productive. Usually, one can find the diverticular neck with 
the nephroscope during the injection of indigo carmine 
through the ureteral balloon catheter. Auge et al described 
an alternative approach if guide wire passage into the main 
collecting system was unsuccessful after several attempts 
[46]. Once inside the cavity, they advance an 18 gauge per-
cutaneous access needle directly through the inner or me-
dial diverticulum wall into the renal collecting system and 
subsequently dilate to 30 Fr with a dilating balloon, creat-
ing a large ‘neoinfundibulotomy’ tract. This maneuver pre-
vents the safety wire from being inadvertently withdrawn. 
With this technique, the connection between the divertic-
ulum and the collecting system is enlarged rather than 
ablated. But in my experience, I never find a diverticulum 
without a diverticular neck. The urothelium of a calyceal 
diverticulum is usually fulgurated with electrocautery or 
a holmium laser if greater than 4 cm in diameter. If electro-
cautery is utilized, the safety wire should be insulated with 
an open-ended catheter to prevent inadvertent trans-
mission of the current down the ureter. The nephrostomy 
catheter is placed through the calyceal diverticulum and 
neoinfundibulotomy and secured in the renal pelvis. There 
are controversies about the duration of a nephrostomy 
catheter. But it tends to be shorter because there is no dif-
ference in success rates according to nephrostomy catheter 
duration [44,46,47]. The results of percutaneous manage-
ment of calyceal diverticula from the literature are pre-
sented in Table 2. In the cases reviewed, stone-free rates 
and symptom-free rates for percutaneous management are Korean J Urol 2010;51:298-307
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FIG. 4. Tuberculous infundibular ste-
nosis. (A) Retrograde pyelography 
showing dilated upper calyces and 
severely narrowed infundibular neck. 
(B) Schematic diagram of percuta-
neous endoinfundibulotomy.
TABLE 2. Results from the literature of percutaneous management of calyceal diverticular calculi
Authors Patients (n) Year published Stone free (%)
Symptom 
free (%)
Diverticular 
obliteration (%) 
Major 
complication (%)
Auge et al [46] 22 2002 78 86 61 9.1
Landry et al [47] 31 2002 84 88 68 0
Monga et al [48] 14 2000 100 NA 100 7.1
Shalhav et al [49] 26 1998 93 85 76 7.7
Kim et al [50] 33 2001 91 96 96 0
Data presented as overall value. NA: not available
consistently 80% or greater. Minor complications during 
percutaneous ablation and calculus removal include hemo-
rrhage, pneumothorax, persistent urinary extravasation, 
and mild extravasation of irrigant. Major complications in-
clude renal pelvis perforation with urinoma formation, 
pneumothorax or hemothorax requiring tube thoracos-
tomy, and massive hemorrhage requiring balloon tam-
ponade. As the table demonstrates, major complications 
are relatively uncommon. 
　Limitations exist primarily for an anteriorly located 
diverticulum. In this situation, if the diverticulum is in a 
superior anterior calyx, the ureteroscopic approach is rec-
ommended, whereas if the diverticulum is in a middle or 
lower anterior calyx, a laparoscopic approach is recom-
mended [44]. The ureteroscopic approach may be an appro-
priate initial treatment option for patients with a small 
stone burden (＜1.5 cm) or patients with comorbidities who 
are poor candidates for PNL.
INFUNDIBULAR STENOSIS
Infundibular stenosis and hydrocalyx are usually an ac-
quired condition associated with inflammation, renal tu-
berculosis, obstructive calculus, or prior renal surgery 
[18,51]. The hydrocalyx should be differentiated from a ca-
lyceal diverticulum because the treatments are different. 
At times, this distinction can be made only by a nephro-
scopy because the presence (hydrocalyx) or absence 
(calyceal diverticulum) of a renal papilla is diagnostic. The 
infundibular narrowing can be resolved in several ways. 
The least difficult approach is to dilate the infundibulum 
to 8 mm with an 8 mm ureteral dilating balloon passed over 
the working guide wire. Alternatively, the infundibulum 
can be cut under endoscopic control with a cold knife 
through a direct vision ureterotome. When the guide wire 
cannot be passed through the stricture, a round tipped rigid 
ureteroscope can be pushed in an antegrade fashion to tra-
verse the stricture with injection of indigo carmine through 
the retrograde ureteral catheter (Fig. 4). According to ana-
tomic studies by Sampaio, the incision should be made 
along the less vascular superior and inferior aspects of the 
middle calyceal infundibulum or the medial and lateral as-
pects of the upper calyceal infundibulum [52]. Reported 
series of endourologically treated infundibular stenosis 
are few. The first Korean case report of endoscopic in-
fundibulotomy was published by Han et al in 1991 [53]. 
Also, Lang reported a 50% success rate in 6 patients with 
infundibular stenosis and caliceal diverticula containing Korean J Urol 2010;51:298-307
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TABLE 3. Results of percutaneous endoscopic therapy for infundibular stenosis
Author  Patients (n) Stent duration (weeks) Success rate (%) Follow up (months)
Schneider et al [56] 9 3-6 67 7-45
Lang [54] 6 4-8 50 24-48
Hwang et al [55] 21 6-8 76 24-90
Overall 36 3-8 68 7-90
stones [54]. Hwang and Park reported an 80% success rate 
in 10 patients with tuberculous infundibular strictures 
who had undergone a cold knife incision; follow-up was 
greater than 1 year [51]. Hwang et al reported long-term 
(more than 2 years follow-up) results with a success rate 
of 76% in 21 patients and better results in the strictures 
with stones than in the strictures with tuberculosis [55]. 
It appears that in contrast to the calyceal diverticulum, in 
which a successful outcome is obtainable in nearly 90% of 
cases, the infundibular stenosis is a more difficult entity 
to treat endourologically, with only a 50% to 76% success 
rate (Table 3).
UPPER TRACT TRANSITIONAL CELL CARCINOMA
Nephroureterectomy with bladder cuff excision has been 
considered the “gold standard” for upper-tract transitional 
cell carcinoma (TCC). In upper-tract TCC, endoscopic sur-
gery could be indicated in those patients with a solitary kid-
ney, bilateral disease, high surgical risk, or chronic renal 
insufficiency and incidental discovery of the tumor [57,58]. 
　The smooth muscle covering the ureter and renal pelvis 
is much thinner than the bladder wall. Therefore, tumors 
in the ureter and renal pelvis can penetrate the wall earlier. 
Indeed, approximately 70% of upper-tract TCCs were of 
moderate or high grade, and more than half had some de-
gree of invasion [59].
　Endoscopic surgery (ureteroscopy and percutaneous 
nephroscopy) has been used in the treatment of upper-tract 
tumors since the 1980s [60-62]. Endoscopic surgery may be 
considered for those patients with low-grade, low-stage 
cancer malignancies under an intensive surveillance pro-
gram. Percutaneous approaches show recurrence rates 
and disease-specific survival in the patients with low- 
grade tumors (Grades 1-2) of 26% to 28% and 96% to 100%, 
respectively [57]. Lee et al compared patients undergoing 
nephroureterectomy versus percutaneous resection and 
noted no statistically significant differences in survival for 
either treatment group (Grades 1, 2, and 3) [63]. Tumor 
grade was the most important prognostic indicator for 
pathologic stage, recurrence rates, and cancer-related 
deaths.
1. Percutaneous surgical technique 
The PCN tract is made to the calyx under fluoroscopy. To 
approach the renal pelvis and upper ureter, a PCN tract 
through the upper-pole or middle posterior calyx is better 
to enable good vision. The tract is dilated up to 30 F to en-
sure a free flow of irrigation fluid at low pressure. The fresh 
tumor tissue is removed with cold-cup forceps and the 
whole tumorous area is fulgurated with electrocautery or 
laser. A 24 Fr nephrostomy tube is placed for a second-look 
nephroscopy 3 to 7 days later. 
　The advantages of the percutaneous approach are the 
use of larger instruments, better vision, complete resection 
of large tumors, deeper biopsies, and better staging [57,64]. 
Also, the percutaneous tract makes it easy to do a second 
look procedure and adjuvant topical therapy. Potential dis-
advantages include the increased morbidity and the theo-
retical concern over tract seeding. However, percutaneous 
tract seeding is rare in patients with upper-tract TCC.
　Typically, a second look procedure is performed within 
several days of the initial procedure. Any remaining tumor 
is treated. Intracavitary adjuvant therapy (BCG or mito-
mycin) can be administered 2 weeks after the resection, as-
suming a nephrostogram is normal.
2. Adjuvant therapy
The most common agents used for topical adjuvant therapy 
are BCG, mitomycin, and thiotepa. Generally, intra-
cavitary placement of these substances is well tolerated 
and the agents can be delivered percutaneously or in a ret-
rograde fashion following ureteroscopy [65]. Six weekly 
courses of intracavitary BCG is recommended, and 2 weeks 
after completion of the full BCG course, third-look nephro-
scopy is recommended. 
　Follow-up of the patients consists of urine cytology study 
at 3 months, intravenous urography at 6 months, cysto-
scopy at 3 and 9 months, and flexible ureteropyeloscopy 
and computed tomography scan at 1 year [64].
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